Exosomal biomarkers in the differential diagnosis of ovarian tumors: the emerging roles of CA125, HE4, and C5a
Abstract Objective Investigating the utility of serum exosomal markers CA125, HE4, and C5a, both individually and in combination, for distinguishing between benign and malignant ovarian tumors. Methods In this study, we selected a total of 234 patients diagnosed with ovarian tumors, including 34 wit...
Saved in:
Main Authors: | Huihui Shi (Author), Liya Liu (Author), Xueli Deng (Author), Xiaoyu Xing (Author), Yan Zhang (Author), Yemeli Djouda Rebecca (Author), Liping Han (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review
by: Vincent Dochez, et al.
Published: (2019) -
Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer
by: Jorge A. Alegría-Baños, et al.
Published: (2021) -
Predicting value of HE4 and CA125 markers for optimal cytoreductive surgery in ovarian cancer patients
by: Elham Saffarieh, et al.
Published: (2022) -
Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer
by: Yan Rong, et al.
Published: (2021) -
Correlation of Molecular Tumor Markers CA125, HE4, and CEA with the Development and Progression of Epithelial Ovarian Cancer
by: Qiuhua Wan, et al.
Published: (2021)